Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment

Systemic lupus erythematosus (SLE) can present with varied neurological manifestations in children. Guillain–Barre syndrome (GBS) as a presenting feature of SLE is quite rare in children. We report a 9-year-old girl who presented with acute motor axonal polyradiculoneuropathy and noticed to have fea...

Full description

Bibliographic Details
Main Authors: Rahul Reddy, Anu Punnen, Annie Bella, Sathish Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=74;epage=76;aulast=Reddy
id doaj-fca150e013e0472da601beba5d98aa36
record_format Article
spelling doaj-fca150e013e0472da601beba5d98aa362020-11-25T00:36:28ZengWolters Kluwer Medknow PublicationsIndian Journal of Rheumatology0973-36980973-37012019-01-01141747610.4103/injr.injr_118_18Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatmentRahul ReddyAnu PunnenAnnie BellaSathish KumarSystemic lupus erythematosus (SLE) can present with varied neurological manifestations in children. Guillain–Barre syndrome (GBS) as a presenting feature of SLE is quite rare in children. We report a 9-year-old girl who presented with acute motor axonal polyradiculoneuropathy and noticed to have features of SLE. She was initially treated with intravenous immunoglobulins and corticosteroids with partial response. After starting rituximab, she showed dramatic recovery, proving the role of rituximab in GBS refractory to first-line medications in SLE. She remained in remission after 12 months of follow-up.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=74;epage=76;aulast=ReddyGuillain–Barre syndromerituximabsystemic lupus erythematosus
collection DOAJ
language English
format Article
sources DOAJ
author Rahul Reddy
Anu Punnen
Annie Bella
Sathish Kumar
spellingShingle Rahul Reddy
Anu Punnen
Annie Bella
Sathish Kumar
Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
Indian Journal of Rheumatology
Guillain–Barre syndrome
rituximab
systemic lupus erythematosus
author_facet Rahul Reddy
Anu Punnen
Annie Bella
Sathish Kumar
author_sort Rahul Reddy
title Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
title_short Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
title_full Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
title_fullStr Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
title_full_unstemmed Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
title_sort guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Rheumatology
issn 0973-3698
0973-3701
publishDate 2019-01-01
description Systemic lupus erythematosus (SLE) can present with varied neurological manifestations in children. Guillain–Barre syndrome (GBS) as a presenting feature of SLE is quite rare in children. We report a 9-year-old girl who presented with acute motor axonal polyradiculoneuropathy and noticed to have features of SLE. She was initially treated with intravenous immunoglobulins and corticosteroids with partial response. After starting rituximab, she showed dramatic recovery, proving the role of rituximab in GBS refractory to first-line medications in SLE. She remained in remission after 12 months of follow-up.
topic Guillain–Barre syndrome
rituximab
systemic lupus erythematosus
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=74;epage=76;aulast=Reddy
work_keys_str_mv AT rahulreddy guillainbarresyndromeasapresentingfeatureofsystemiclupuserythematosusinachildanditscompleteresolutionwithrituximabtreatment
AT anupunnen guillainbarresyndromeasapresentingfeatureofsystemiclupuserythematosusinachildanditscompleteresolutionwithrituximabtreatment
AT anniebella guillainbarresyndromeasapresentingfeatureofsystemiclupuserythematosusinachildanditscompleteresolutionwithrituximabtreatment
AT sathishkumar guillainbarresyndromeasapresentingfeatureofsystemiclupuserythematosusinachildanditscompleteresolutionwithrituximabtreatment
_version_ 1725305144920244224